Registration for a live webinar on 'Chronic inflammation, immune cell trafficking and anti-trafficking agents' is now open.See webinar details
What’s new for IgA nephropathy part 2: clinical presentation, diagnosis, prognosis, treatment
Published on August 31, 2016 23 min
Other Talks in the Series: The Kidney in Health and Disease
What’s new for IgA nephropathy part 1: epidemiology and pathogenesis
- Prof. Maurizio Salvadori
- University of Florence, Italy
This is my second presentation on IgA Nephropathy. I'm Professor Salvadori from the University of Florence.
This time I will discuss with you the second part of IgA nephropathy. That is the clinical presentation, the diagnosis, the prognosis and finally the treatment. This will be the agenda of my presentation. But let me start with the clinical presentation.
Overall there are five different categories of patients that are affected by IgA nephropathy with different clinical presentations. There are patients who are diagnosed accidentally, with no symptoms. Patients affected by a recurrent macroscopic hematuria. Patients with rapidly progressive renal disease. Patients with IgA nephropathy recurrence after kidney transplantation. And finally, patients with acute kidney injury due to macroscopic hematuria.
Patients diagnosed accidentally, they are often found while looking for clinical manifestations such as reduced a glomerular filtration rate, hypertension, or urinary abnormalities. These patients represent the silent majority.
The second patients are those affected by macroscopic hematuria. Patients affected by macroscopic hematuria, often recur the hematuria after acute infective disease, occurred in the upper respiratory tract. These patients are called the typical IgA nephropathy patients.